Abviva, Inc. (Pink Sheets: ABVV)
Santa Barbara, CA 93101 (Map) Phone: 800-970-5870
Fax: 800-970-5874
http://www.abviva.com
Overview
Abviva aims to bring better diagnostics to the fight against breast cancer. The drug developer (formerly known as Genesis Bioventures) is working on proteomics-based cancer diagnostics and therapeutics. Its wholly owned subsidiary Biomedical Diagnostics has developed a blood test, called the Mammastatin Serum Assay, which assesses a person's risk for developing breast cancer. Abviva also has a significant stake in Prion Developmental Laboratories, a developer of diagnostic tools for Mad Cow Disease and a similar neurodegenerative disorder that affects deer and elk called Chronic Wasting Disease.
Key Numbers from Hoover's UK
Key financials for Abviva, Inc. (Pink Sheets: ABVV)
| Company Type | Public (Pink Sheets: ABVV) |
|---|---|
| Fiscal Year-End | December |
Key People from Hoover's UK
Key people and executives for Abviva, Inc. (Pink Sheets: ABVV)
| President, CEO, and Director | Douglas Lane (Subscribers see complete biographies -- view sample)
|
|---|
Top Competitors from Hoover's UK
Top competitors of Abviva, Inc. (Pink Sheets: ABVV)
There are 12 competitors for Abviva; see more.
